Literature DB >> 12432246

Four birds with one stone: RAPA as potential anticancer therapy.

Mikhail V Blagosklonny1, Zbigniew Darzynkiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12432246

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  6 in total

Review 1.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

2.  Rapamycin: killing two birds with one stone.

Authors:  Amit Khanna; Pankaj Kapahi
Journal:  Aging (Albany NY)       Date:  2011-11       Impact factor: 5.682

3.  Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture.

Authors:  Pasha Apontes; Olga V Leontieva; Zoya N Demidenko; Fengzhi Li; Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2011-03

4.  TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin.

Authors:  Jose Felix Moruno-Manchon; Ndidi-Ese Uzor; Shelli R Kesler; Jeffrey S Wefel; Debra M Townley; Archana Sidalaghatta Nagaraja; Sunila Pradeep; Lingegowda S Mangala; Anil K Sood; Andrey S Tsvetkov
Journal:  Aging (Albany NY)       Date:  2016-12-16       Impact factor: 5.682

Review 5.  Immunosuppressants in cancer prevention and therapy.

Authors:  Mikhail V Blagosklonny
Journal:  Oncoimmunology       Date:  2013-11-06       Impact factor: 8.110

6.  Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma.

Authors:  Wei-Lin Liu; Ming Gao; Kai-Yuan Tzen; Chiao-Ling Tsai; Feng-Ming Hsu; Ann-Lii Cheng; Jason Chia-Hsien Cheng
Journal:  Oncotarget       Date:  2014-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.